ARCHIVES

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993

DCE Board Approves Support Contract Recompetition

July 6, 1990

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975